Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia: an Observational, Non-interventional Study
Phase of Trial: Phase IV
Latest Information Update: 20 May 2018
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Europe
- 14 Jul 2017 Planned End Date changed from 1 Sep 2018 to 1 Nov 2018.
- 14 Jul 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Nov 2018.
- 14 Jul 2017 Status changed from not yet recruiting to recruiting.